1173 related articles for article (PubMed ID: 16513288)
21. Isoflavonoid-based bone-sparing treatments exert a low activity on reproductive organs and on hepatic metabolism of estradiol in ovariectomized rats.
Phrakonkham P; Chevalier J; Desmetz C; Pinnert MF; Bergès R; Jover E; Davicco MJ; Bennetau-Pelissero C; Coxam V; Artur Y; Canivenc-Lavier MC
Toxicol Appl Pharmacol; 2007 Oct; 224(2):105-15. PubMed ID: 17655901
[TBL] [Abstract][Full Text] [Related]
22. The rat prepubertal uterine myometrium and not the luminal epithelium is predominantly affected by a chronic dietary genistein exposure.
Möller FJ; Ledwig C; Zierau O; Hertrampf T; Degen GH; Diel P; Vollmer G
Arch Toxicol; 2012 Dec; 86(12):1899-910. PubMed ID: 22811025
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones.
Constantinou AI; Mehta RG; Vaughan A
Anticancer Res; 1996; 16(6A):3293-8. PubMed ID: 9042303
[TBL] [Abstract][Full Text] [Related]
24. Soy isoflavones and cognitive function.
Lee YB; Lee HJ; Sohn HS
J Nutr Biochem; 2005 Nov; 16(11):641-9. PubMed ID: 16169201
[TBL] [Abstract][Full Text] [Related]
25. Multiple mechanisms of soy isoflavones against oxidative stress-induced endothelium injury.
Xu SZ; Zhong W; Ghavideldarestani M; Saurabh R; Lindow SW; Atkin SL
Free Radic Biol Med; 2009 Jul; 47(2):167-75. PubMed ID: 19393315
[TBL] [Abstract][Full Text] [Related]
26. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.
Messina M; McCaskill-Stevens W; Lampe JW
J Natl Cancer Inst; 2006 Sep; 98(18):1275-84. PubMed ID: 16985246
[TBL] [Abstract][Full Text] [Related]
27. Differential effect of pure isoflavones and soymilk on estrogen receptor activity in mice.
Rando G; Ramachandran B; Rebecchi M; Ciana P; Maggi A
Toxicol Appl Pharmacol; 2009 Jun; 237(3):288-97. PubMed ID: 19361539
[TBL] [Abstract][Full Text] [Related]
28. Can the combination of flaxseed and its lignans with soy and its isoflavones reduce the growth stimulatory effect of soy and its isoflavones on established breast cancer?
Power KA; Thompson LU
Mol Nutr Food Res; 2007 Jul; 51(7):845-56. PubMed ID: 17579892
[TBL] [Abstract][Full Text] [Related]
29. Isoflavones and bone: animal and human evidence of efficacy.
Chen X; Anderson JJ
J Musculoskelet Neuronal Interact; 2002 Jun; 2(4):352-9. PubMed ID: 15758427
[TBL] [Abstract][Full Text] [Related]
30. [Phytoestrogens].
Zittermann A
Zentralbl Gynakol; 2003 Jun; 125(6):195-201. PubMed ID: 14556117
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of estrogen receptor beta in breast cancer.
Saji S; Hirose M; Toi M
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():21-6. PubMed ID: 16273360
[TBL] [Abstract][Full Text] [Related]
32. Enhanced estrogenic responses and sensitivity to azoxymethane following dietary soy isoflavone supplementation in older female rats.
Daly KT; Tracy AC; Malik M; Wang T; Francke-Carroll S; Magnuson BA
Food Chem Toxicol; 2007 Apr; 45(4):628-37. PubMed ID: 17157426
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
[TBL] [Abstract][Full Text] [Related]
34. The effect of glucuronidation on isoflavone induced estrogen receptor (ER)α and ERβ mediated coregulator interactions.
Beekmann K; de Haan LH; Actis-Goretta L; Houtman R; van Bladeren PJ; Rietjens IM
J Steroid Biochem Mol Biol; 2015 Nov; 154():245-53. PubMed ID: 26361015
[TBL] [Abstract][Full Text] [Related]
35. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010).
North American Menopause Society
Menopause; 2011 Jul; 18(7):732-53. PubMed ID: 21685820
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of reactive nitrogen species effects in vitro and in vivo by isoflavones and soy-based food extracts.
Yen GC; Lai HH
J Agric Food Chem; 2003 Dec; 51(27):7892-900. PubMed ID: 14690370
[TBL] [Abstract][Full Text] [Related]
37. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro.
Hedlund TE; Johannes WU; Miller GJ
Prostate; 2003 Jan; 54(1):68-78. PubMed ID: 12481257
[TBL] [Abstract][Full Text] [Related]
38. Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist.
Jackson RL; Greiwe JS; Schwen RJ
Nutr Rev; 2011 Aug; 69(8):432-48. PubMed ID: 21790611
[TBL] [Abstract][Full Text] [Related]
39. WHI and WHIMS follow-up and human studies of soy isoflavones on cognition.
Zhao L; Brinton RD
Expert Rev Neurother; 2007 Nov; 7(11):1549-64. PubMed ID: 17997703
[TBL] [Abstract][Full Text] [Related]
40. Long-term dietary isoflavone exposure enhances estrogen sensitivity of rat uterine responsiveness mediated through estrogen receptor alpha.
Möller FJ; Diel P; Zierau O; Hertrampf T; Maass J; Vollmer G
Toxicol Lett; 2010 Jul; 196(3):142-53. PubMed ID: 20381596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
